FDA Inspection 920919 — Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
The FDA completed an inspection of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd on March 27, 2015 in Heze. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 27, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Heze (China)